Abstract
Overcoming drug resistance in malaria parasites against available drugs is possible by using drug hybrids, as reported by S. B. Tsogoeva, L. Ackermann, J. Wang, and co-workers in their Research Article on page 13066 ff. The merging of two differently acting drugs (e.g., artemisinin and chloroquine) in one hybrid compound gives simultaneous cellular uptake of the pharmacophore components of the hybrid, and dual action is achieved, thereby enabling novel functions targeting pathogens, multidrug resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
